Literature DB >> 19051574

Risks and benefits of antipsychotic drugs in elderly patients with dementia.

Robert H Howland1.   

Abstract

Memory impairment and other cognitive disturbances characterize dementia, but other noncognitive behavioral and psychiatric symptoms are very common. The most important behavioral and psychiatric symptoms associated with dementia (BPSAD) are agitation, aggression, and psychosis, and they have serious consequences for patients and caregivers. No medication has been approved for the treatment of BPSAD, but antipsychotic drugs are the best studied and most commonly used. However, in addition to these drugs' expected side effects, cerebrovascular adverse events and death are two serious adverse effects associated with their use in dementia patients. This article highlights the studies examining the risks and benefits of antipsychotic drugs for BPSAD. Weighing small but significant risks compared with possible benefits is a complex treatment decision.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19051574     DOI: 10.3928/02793695-20081101-05

Source DB:  PubMed          Journal:  J Psychosoc Nurs Ment Health Serv        ISSN: 0279-3695            Impact factor:   1.098


  2 in total

Review 1.  Hallucinations in Parkinson disease.

Authors:  Nico J Diederich; Gilles Fénelon; Glenn Stebbins; Christopher G Goetz
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

2.  Comparison of the efficacy of aroma-acupressure and aromatherapy for the treatment of dementia-associated agitation.

Authors:  Man-Hua Yang; Li-Chan Lin; Shiao-Chi Wu; Jen-Hwey Chiu; Pei-Ning Wang; Jaung-Geng Lin
Journal:  BMC Complement Altern Med       Date:  2015-03-29       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.